ORIGINAL RESEARCH
Published on 29 May 2024
Generating universal anti-CD19 CAR T cells with a defined memory phenotype by CRISPR/Cas9 editing and safety evaluation of the transcriptome
doi 10.3389/fimmu.2024.1401683
- 4,837 views
- 7 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II
Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II
30k
Total downloads
88k
Total views and downloads
Articles
REVIEW
Published on 07 Dec 2023
CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer
doi 10.3389/fimmu.2023.1302307
- 5,290 views
- 13 citations
REVIEW
Published on 28 Nov 2023
Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils
doi 10.3389/fimmu.2023.1291619
- 5,455 views
- 19 citations
ORIGINAL RESEARCH
Published on 27 Oct 2023
Mediport use as an acceptable standard for CAR T cell infusion
doi 10.3389/fimmu.2023.1239132
- 3,889 views
ORIGINAL RESEARCH
Published on 18 Oct 2023
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
doi 10.3389/fimmu.2023.1187665
- 4,160 views
- 10 citations
ORIGINAL RESEARCH
Published on 17 Oct 2023
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
doi 10.3389/fimmu.2023.1219165
- 3,389 views
- 3 citations
REVIEW
Published on 15 Aug 2023
Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
doi 10.3389/fimmu.2023.1202950
- 6,232 views
- 14 citations
CASE REPORT
Published on 29 Nov 2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase
doi 10.3389/fimmu.2022.1012981
- 4,245 views
- 10 citations
REVIEW
Published on 22 Nov 2022
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
doi 10.3389/fimmu.2022.1018786
- 17,074 views
- 53 citations
ORIGINAL RESEARCH
Published on 06 Oct 2022
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
doi 10.3389/fimmu.2022.1011858
- 6,029 views
- 16 citations
ORIGINAL RESEARCH
Published on 28 Sep 2022
Transcriptional states of CAR-T infusion relate to neurotoxicity – lessons from high-resolution single-cell SOM expression portraying
doi 10.3389/fimmu.2022.994885
- 3,179 views
- 5 citations
ORIGINAL RESEARCH
Published on 23 Aug 2022
Impact of glucocorticoids on short-term and long-term outcomes in patients with relapsed/refractory multiple myeloma treated with CAR-T therapy
doi 10.3389/fimmu.2022.943004
- 2,637 views
- 13 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore